Can the routine treatment of Graves' orbitopathy be efficiently supplemented by the administration of Venalot?
Frank
K
K
Abteilung Innere Medizin I, Universitätsklinik, Heidelberg, FRG.
Ding
G
G
Raue
F
F
Ziegler
R
R
D002986:Clinical Trials as Topic; D003374:Coumarins / Q000627:therapeutic use*; D004311:Double-Blind Method; D004338:Drug Combinations / Q000627:therapeutic use; D004700:Endocrine System Diseases / Q000188:drug therapy; D005500:Follow-Up Studies; D006111:Graves Disease / Q000188:drug therapy* / Q000532:radiotherapy; D006801:Humans; D006896:Hydroxyethylrutoside / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012431:Rutin / Q000031:analogs & derivatives*; D013960:Thyroid Function Tests
D003374:Coumarins; D004338:Drug Combinations; D006896:Hydroxyethylrutoside; C013731:Venalot; D012431:Rutin